Concepedia

Constantine Mitsiades

CM

Statistics

Publications

20

Citations

3.2K

H-Index

18

Active since

2001

Affiliations

Dana-Farber Cancer Institute(Current)

Harvard University

VA Boston Healthcare System

Massachusetts Eye and Ear Infirmary

Dana-Farber/Harvard Cancer Center

Constantine Mitsiades is an author at Dana-Farber Cancer Institute specializing in multiple myeloma, multiple myeloma treatment, and medicine.

Publications per year

2001–2013

20

Publications

20

Molecular sequelae of proteasome inhibition in human multiple myeloma cells

Nicholas Mitsiades, Constantine Mitsiades, Vassiliki Poulaki et al. · Proceedings of the National Academy of Sciences · 2002 · 748 citations · Full text

, , +16

Proteasome inhibitor PS-341 inhibits human myeloma cell growth in vivo and prolongs survival in a murine model.

Richard LeBlanc, Laurence Catley, Teru Hideshima et al. · PubMed · 2002 · 456 citations

, , +13

Nuclear factor-kappaB p65 mediates tumor necrosis factor alpha-induced nuclear translocation of telomerase reverse transcriptase protein.

Masaharu Akiyama, Teru Hideshima, Toshiaki Hayashi et al. · PubMed · 2003 · 214 citations

, , +17

Targeting the β-catenin/TCF transcriptional complex in the treatment of multiple myeloma

Kumar Sukhdeo, Mala Mani, Yunyu Zhang et al. · Proceedings of the National Academy of Sciences · 2007 · 210 citations · Full text

, , +16

Phase I trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) in patients with advanced multiple myeloma

Paul G. Richardson, Constantine Mitsiades, Kathleen Colson et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2008 · 191 citations

, , +15

1–5 of 20